![Triple Antibiotic First Aid 3.5 mg/g; 400 [iU]/g; 5000 [iU]/g Ointment, 1 tube — NDC 68001-0483-45 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c47e15bd-1062-4cca-e053-2995a90a9075&name=TRIPLE+ANTIBIOTIC+OINTMENT++Carton+.5oz++Rev+09+2021.jpg)
Triple Antibiotic First Aid 3.5 mg/g; 400 [iU]/g; 5000 [iU]/g Ointment, 1 tube
by BluePoint Laboratories · 1 TUBE in 1 CARTON (68001-483-45) / 28.4 g in 1 TUBE
NDC 68001-0483-45
🏷️ FDA NDC (as labeled)
68001-483-45
billing pads the product segment with a zero
This package
Also priced by: Medicaid pays $0.4098/unit — full pricing hub ↓
Also comes in:
14.2 g 68001-0483-46
OTC
On market
Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
68001-483-45
Product NDC
68001-483
11-digit billing NDC
68001048345
NCPDP billing unit
GM — per gram (weight)
RxCUI
204602
UNII
057Y626693, 89Y4M234ES, 19371312D4
Application #
M004
SPL Set ID
c47e15bd-1062-4cca-e053-2995a90a9075
Established class (EPC)
Aminoglycoside Antibacterial; Polymyxin-class Antibacterial
Physiologic effect
Decreased Cell Wall Synthesis & Repair
Chemical class
Aminoglycosides; Polymyxins
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2021-06-15
Route
TOPICAL
Dosage form
OINTMENT
Substance
NEOMYCIN SULFATE; BACITRACIN ZINC; POLYMYXIN B SULFATE
GPI-14
90109803104200
GPI class
Triple Antibiotic
GCN Seq No
007694
GCN
85459
HICL code
033356
Ingredient (HICL)
Neomycin/Bacitracin/Polymyxinb
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q5
Therapeutic class — intermediate (HIC2)
Agents Acting Principally On The Skin
HIC3 code
Q5W
Therapeutic class — specific (HIC3)
Topical Antibiotics
AHFS code
08:12.28.08
AHFS class
Bacitracin Antibiotics
FDB label name
TRIPLE ANTIBIOTIC OINTMENT
FDB brand name
Triple Antibiotic
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 68001-483-45 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68001-0483-45. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Other antibiotics for topical use class.
Drug family (ATC)
Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerBluePoint Laboratories
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code68001
First marketedJun 2021
Product typeHuman Otc Drug
Portfolio347 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name TRIPLE ANTIBIOTIC OINTMENT Ingredient Neomycin/Bacitracin/Polymyxinb
📖 What it is MedlinePlus · NLM
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- It's a first-aid antibiotic you apply to small, everyday wounds — minor cuts, scrapes, and burns — to help prevent a bacterial infection from developing. Some products also help te...
- What is this triple antibiotic ointment actually for?
- Start by cleaning the wound area. Then apply a small amount — about the size of your fingertip — directly on the area up to 1 to 3 times a day. You can cover it with a sterile band...
- Most people don't have any trouble with it. The most common reaction is a mild skin irritation, redness, itching, or swelling at the spot you applied it. If you use it often, you c...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about First Aid Antibiotic?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII B6E5W8RQJ4
White petrolatum is a purified mineral oil product used as a lubricant and skin protectant in medications. It helps pills slide through manufacturing equipment and can soften or protect the skin when applied topically.
1 inactive ingredient listed in the exact product block matched to this NDC.
The official label also statesWhite Petrolatum
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.110 | $3.14 / 28.4 g |
| Medicaid paysCMS SDUD · 12 mo | $0.4098 | $11.64 / 28.4 g |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per g) — tap or hover for the price & month
▲ Up 21% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2021
On the market since
Jun 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 68001-0483-45, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
5.7K
Units reimbursed last 4 qtrs
174K
Gross reimbursed last 4 qtrs
$71.3K
Avg / prescription
$12.46
Avg / unit
$0.4098
Latest quarter Q4 2025
1.4KRx
Medicaid pays / g
$0.4098
gross reimbursed
vs
NADAC / g
$0.1104
acquisition cost
=
Spread
+$0.2994
+271% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 4,687 Rx Managed care · 1,036 Rx
State Medicaid map
Units reimbursed · per 100k residents
4.8348
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 8,707 Rx · 220,410 units · $96,921 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Triple Antibiotic (this brand).
Top reported reactions
Reporter sex
Male · 34%
Female · 66%
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 68001-0483-45 You're viewing this | 1 TUBE in 1 CARTON (68001-483-45) / 28.4 g in 1 TUBE | $0.1104 / g | $3.13 | 2021-06-15 | Active |
| 68001-0483-46 | 1 TUBE in 1 CARTON (68001-483-46) / 14.2 g in 1 TUBE | $0.1393 / g | $1.98 | 2021-06-15 | Active |
This pack has the lowest per-g cost of the 2 priced pack sizes ($0.1104 NADAC).
In Medicaid, this is the most-dispensed pack of this product — about 66% of fills over the last four reported quarters. See all packs ↓
Pack size FAQ
What quantity is in NDC 68001-0483-45?
NDC 68001-0483-45 contains 1 tube — 1 tube in 1 carton / 28.4 g in 1 tube.
What is the difference between NDC 68001-0483-45 and NDC 68001-0483-46?
Both are Triple Antibiotic First Aid 3.5 mg/g; 400 [iU]/g; 5000 [iU]/g Ointment — the drug itself is identical. NDC 68001-0483-45 is the 1 tube package, while NDC 68001-0483-46 is the 1 tube package. Per-g NADAC also differs: $0.1104 here vs $0.1393 for the 1 tube pack.
What NDC number is used to bill for this package of Triple Antibiotic First Aid 3.5 mg/g; 400 [iU]/g; 5000 [iU]/g Ointment?
Bill NDC 68001-0483-45 — the 11-digit billing format is 68001048345. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses First Aid to help prevent infection in minor cuts, scrapes and burns
⏱️ Dosage and Administration ▾
Directions Clean the affected area. Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily. May be covered with a sterile bandage.
⚠️ Warnings ▾
Warnings For external use only.
📦 Storage and Handling ▾
Other information Do not use if seal on the tube is damaged or is not visible. To open, unscrew cap, pull tab to remove foil seal. Store at room temperatue Preserve in well-closed containers See crimp of tube or carton for Lot Number and Expiry Date
🧪 Active Ingredient ▾
Active ingredients Bacitracin Zinc (400 units in each gram) Neomycin Sulfate 5mg (equivalent to 3.5mg Neomycin per gram) Polymyxin B Sulfate (5000 units per gram)
🧪 Inactive Ingredients ▾
Inactive ingredients White Petrolatum
🎯 Purpose ▾
Purpose First Aid Antibiotics
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.